Express News | Genprex Shares Are Trading Higher After the Company Announced Its Research Collaborators Published a Study on Gene Therapy and Antitumor Immunity

BenzingaFeb 13 13:39 ET

Genprex's Oncoprex Included in Lung Cancer Therapy

TipRanksFeb 13 08:28 ET

Genprex Collaborators Find NPRL2 Gene Therapy Using Oncoprex Delivery System Is a Potential Treatment for Anti-PD1 Resistant Non-Small Cell Lung Cancer

PR NewswireFeb 13 08:15 ET

Why Lattice Semiconductor Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket

BenzingaFeb 11 05:53 ET

Genprex Announces First Patient Dosed With Regorsa in Phase 2 Lung Cancer Study

TipRanksJan 23 08:11 ET

Genprex Announces First Patient Enrolled In Acclaim-3 Phase 2 Study For ES-SCLC; 25 Patients To Complete Enrollment In H2 2025; Study Has FDA Orphan Drug And Fast Track Designations

BenzingaJan 23 08:01 ET